Can VR brain training ease teen migraines at home?

NCT ID NCT07454798

Recruiting now Symptom relief Sponsor: Children's Mercy Hospital Kansas City Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a home-based virtual reality (VR) neurofeedback program is practical and helpful for adolescents aged 10-16 with migraine. Participants use a wearable EEG headband that reads brain activity and guides the VR experience during short sessions three times a week for four weeks. The goal is to see if teens can stick with the program and if it reduces headache disability compared to a VR imagery program without neurofeedback.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Immersive Neurofeedback Self-Regulation Training (INSeRT) using a wearable EEG headband and virtual reality
What this could lead to: If this works, it could offer a non-drug, home-based option to help teens manage migraine symptoms and reduce headache-related disability.
What could go wrong: This is a small, early feasibility study with only 38 participants, so results may not apply widely. The neurofeedback effect is compared to VR imagery alone, and benefits may be modest or absent.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEADACHE DISORDERS, PRIMARY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

headache disorder hypnic headache migraine disorder Self-Control

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEADACHE DISORDERS, PRIMARY MIGRAINE

Contacts and locations

Locations

Children's Mercy
RECRUITING

Kansas City, Missouri, 64108, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.